1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
BARDA's Programs to Combat Emerging Infectious Diseases is sponsored by Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), HHS. BARDA invests in new approaches and technologies to accelerate the development of vaccines, therapeutic products, and diagnostic tests needed to respond to emerging threats, including Ebola.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Industry, academic institutions, and other stakeholders with capabilities in medical countermeasure research, development, and manufacturing. Confirm the full requirements in the official notice before applying.
BARDA's Programs to Combat Emerging Infectious Diseases is funded by Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), HHS. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Broad Agency Announcement for the Advanced Research and Development of Medical Countermeasures (BAA-23-100-SOL-00004) is sponsored by Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), HHS. This BAA solicits proposals for the advanced research and development of medical countermeasures (MCMs) such as vaccines, therapeutics, diagnostics, and devices to counter chemical, biological, radiological, and nuclear threats, pandemic influenza, and emerging infectious diseas…
Broad Agency Announcement for the Advanced Research and Development of Medical Countermeasures is sponsored by Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), HHS. BARDA solicits proposals for the advanced research and development of medical countermeasures (MCMs) for chemical, biological, radiological, and nuclear (CBRN) agents, pandemic influenza, and emerging infectious diseases, including therapeutics for Ebolavirus and Marburgvirus.
BARDA Accelerator Network 2.0 - Supplemental Announcement to Fill Diagnostics and Medical Devices Hub Vacancy is sponsored by Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), HHS. BARDA seeks to establish a partnership to build the next iteration of the Diagnostics/Medical Devices Hub as part of the BARDA Accelerator Network (BAN 2. 0).
NOT-RM-26-004 asks the public for NIH-wide research challenges worth a 10-year, cross-institute program. There is no budget, no biosketch, no page limit, and no award. What there is: the five criteria every Common Fund investment has met since 2006, a new bullet about small-lab burden, and a fund whose FY 2026 request came in at $347.4 million — down 49.3 percent.
Read articleOn August 25, 2026 a Ninth Circuit panel affirmed most of a sweeping injunction against HUD, DOT, and HHS grant conditions covering roughly $14 billion. The opinion sorts conditions into four buckets — and only one of them holds up. Here is what changed for every recipient of a federal award.
Read articleUSDA and HHS announced Harvest to Hallways on August 24, 2026: $50M in new cafeteria infrastructure funding on top of $20M in Equipment Assistance Grants, up to $25M more in Patrick Leahy Farm to School awards for FY2026, and $30M in HHS nutrition research. Each pot has a different applicant, a different route, and a different timeline. Here is how to position for all three before the notices post.
Read article